Across TCGA pan-cancer cohorts, LINC01326 RNA differs between tumor and matched normal tissue in 1 of 18 cancer types tested, making tumor–normal expression one of LINC01326’s most consistent transcriptional readouts.
The strongest signal is observed in lung squamous cell carcinoma (LUSC), where LINC01326 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types LINC01326 is over-expressed in tumor.
LUSC are the cancer types where LINC01326 tumor–normal differential expression is most reproducible.